<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2170">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on September 19, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01737281</url>
  </required_header>
  <id_info>
    <org_study_id>IIR 11-291</org_study_id>
    <secondary_id>1I01HX000817-01A2</secondary_id>
    <nct_id>NCT01737281</nct_id>
  </id_info>
  <brief_title>Proactive Outreach for Smokers in VA Mental Health</brief_title>
  <acronym>PROMH</acronym>
  <official_title>Proactive Outreach for Smokers in VA Mental Health</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Veterans with a mental health diagnosis have higher a prevalence of smoking and higher rates&#xD;
      of smoking-related morbidities compared to the general Veteran population. Smoking cessation&#xD;
      treatment delivery in the VA typically depends on a visit from a health care provider. In&#xD;
      this study, investigators will use information within the electronic medical record to&#xD;
      identify all smokers with a mental health diagnosis at a VA health care facility and&#xD;
      proactively reach out to enroll them in an intensive tobacco cessation treatment program.&#xD;
      This approach could be generalized to other behaviors and provides a novel method to improve&#xD;
      the health of an entire population of patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background:&#xD;
&#xD;
      Tobacco use is the leading preventable cause of death in the United States and contributes up&#xD;
      to 24% of all VA healthcare costs. Veterans enrolled in the VA healthcare system smoke&#xD;
      substantially more than the general population, which is particularly true among Veterans&#xD;
      diagnosed with mental illness. Patients with bipolar disorder or schizophrenia have the&#xD;
      highest smoking rates (69% and 58-90%, respectively) followed by those with PTSD (45-63%) and&#xD;
      depression (31-51%). Numerous barriers exist for tobacco cessation among mental health&#xD;
      patients, including high nicotine dependency, low rates of follow through for referrals, and&#xD;
      limited availability of tobacco treatment tailored to their needs.&#xD;
&#xD;
      Rationale:&#xD;
&#xD;
      Most medical care providers assess tobacco use and advise smokers to quit, but they have&#xD;
      insufficient time to follow up with treatment, leading to low long-term quit rates. Mental&#xD;
      health providers who often meet regularly with patients report that they find tobacco&#xD;
      cessation outside the scope of their practice and neither assess tobacco use nor refer&#xD;
      smokers for treatment. These practice patterns have been very difficult to change even with&#xD;
      intensive methods and across various settings and provider types. Therefore, the&#xD;
      investigators here propose to use the electronic medical record system to identify smokers&#xD;
      receiving mental health care and proactively reach out to engage them in treatment in line&#xD;
      with the following aims:&#xD;
&#xD;
      Specific Aims:&#xD;
&#xD;
        1. Compare the reach and efficacy of a proactive outreach telephone-based tobacco cessation&#xD;
           (PRO) program for patients seen in mental health to usual care (UC) advice and referral&#xD;
           to local VA and community tobacco cessation resources.&#xD;
&#xD;
        2. Model longitudinal associations between baseline sociodemographic, medical and mental&#xD;
           health characteristics and abstinence at 6 and 12 months in the PRO and UC conditions.&#xD;
&#xD;
      Methods:&#xD;
&#xD;
      Investigators will use the electronic medical record to identify N=6,400 patients across 4 VA&#xD;
      healthcare facilities who have a clinical reminder code indicating current tobacco use in the&#xD;
      past year and who have had a mental health visit in the past 6 months. Investigators will&#xD;
      send each patient an introductory letter and baseline survey. Respondents will be randomized&#xD;
      in a 1:1 fashion to intervention or control. Control participants will receive VA usual care.&#xD;
      Intervention participants will receive proactive telephone counseling and cessation&#xD;
      medications. Investigators will assess tobacco use at 6 and 12 months from enrollment. The&#xD;
      primary outcome is cotinine-validated abstinence at the 12-month follow-up.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2014</start_date>
  <completion_date type="Actual">June 30, 2018</completion_date>
  <primary_completion_date type="Actual">June 30, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Cotinine-Validated Abstinence From Smoking</measure>
    <time_frame>12 months</time_frame>
    <description>The primary outcome will be cotinine-validated abstinence from smoking at 12-month follow-up.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Self-Reporting 7-Day Abstinence From Cigarettes</measure>
    <time_frame>12 months</time_frame>
    <description>At 12 month follow-up, participants were asked if the had smoked any cigarettes in the last 7 days</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1938</enrollment>
  <condition>Smoking</condition>
  <arm_group>
    <arm_group_label>Proactive outreach</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Proactive outreach to deliver 7 sessions of telephone counseling and nicotine replacement therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Usual smoking cessation care from clinical staff</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Proactive outreach</intervention_name>
    <description>Proactive contact (mail and phone) offering smoking cessation medications and telephone counseling.</description>
    <arm_group_label>Proactive outreach</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Usual care</intervention_name>
    <description>Usual smoking cessation care from VA clinical staff.</description>
    <arm_group_label>Usual care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Current smoker (i.e., any tobacco use in past 30 days)&#xD;
&#xD;
          -  Seen in VA Mental Health Clinic in prior 12 months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Dementia&#xD;
&#xD;
          -  Does not speak English&#xD;
&#xD;
          -  Does not have a telephone and mailing address (necessary to mail out consent materials&#xD;
             and to deliver the telephone-based intervention)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Scott E Sherman, MD MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Steven S. Fu, MD MSCE</last_name>
    <role>Principal Investigator</role>
    <affiliation>Minneapolis VA Health Care System, Minneapolis, MN</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>James A. Haley Veterans' Hospital, Tampa, FL</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Minneapolis VA Health Care System, Minneapolis, MN</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55417</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Michael E. DeBakey VA Medical Center, Houston, TX</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Rogers ES, Fu SS, Krebs P, Noorbaloochi S, Nugent SM, Rao R, Schlede C, Sherman SE. Proactive outreach for smokers using VHA mental health clinics: protocol for a patient-randomized clinical trial. BMC Public Health. 2014 Dec 17;14:1294. doi: 10.1186/1471-2458-14-1294.</citation>
    <PMID>25518878</PMID>
  </results_reference>
  <results_reference>
    <citation>Hammett P, Fu SS, Lando HA, Owen G, Okuyemi KS. The association of military discharge variables with smoking status among homeless Veterans. Prev Med. 2015 Dec;81:275-80. doi: 10.1016/j.ypmed.2015.09.007. Epub 2015 Sep 21.</citation>
    <PMID>26400636</PMID>
  </results_reference>
  <results_reference>
    <citation>Rogers ES, Fu SS, Krebs P, Noorbaloochi S, Nugent SM, Gravely A, Sherman SE. Proactive Tobacco Treatment for Smokers Using Veterans Administration Mental Health Clinics. Am J Prev Med. 2018 May;54(5):620-629. doi: 10.1016/j.amepre.2018.02.011. Epub 2018 Mar 15.</citation>
    <PMID>29551324</PMID>
  </results_reference>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>November 27, 2012</study_first_submitted>
  <study_first_submitted_qc>November 27, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 29, 2012</study_first_posted>
  <results_first_submitted>November 19, 2018</results_first_submitted>
  <results_first_submitted_qc>November 19, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">March 14, 2019</results_first_posted>
  <last_update_submitted>March 18, 2019</last_update_submitted>
  <last_update_submitted_qc>March 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Smoking</keyword>
  <keyword>Tobacco control</keyword>
  <keyword>Counseling</keyword>
  <keyword>mental health</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 8, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/81/NCT01737281/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Proactive Outreach</title>
          <description>Proactive outreach to deliver 7 sessions of telephone counseling and nicotine replacement therapy.&#xD;
Proactive outreach: Proactive contact (mail and phone) offering smoking cessation medications and telephone counseling.</description>
        </group>
        <group group_id="P2">
          <title>Usual Care</title>
          <description>Usual smoking cessation care from clinical staff&#xD;
Usual care: Usual smoking cessation care from VA clinical staff.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="969"/>
                <participants group_id="P2" count="969"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="603"/>
                <participants group_id="P2" count="689"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="366"/>
                <participants group_id="P2" count="280"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Proactive Outreach</title>
          <description>Intervention arm participants received: (1) 12 sessions of proactive telephone cessation counseling, (2) coordination of cessation medications from a VA provider, (3) mailed stress reduction materials, (4) engagement of their regular mental health provider in the treatment process through CPRS progress notes, to which their provider will be added as signer.</description>
        </group>
        <group group_id="B2">
          <title>Usual Care</title>
          <description>Control arm participants received a mailed list of local VA and non-VA smoking cessation services that they can access on their own. In addition, patients randomized to the control group received treatment or referrals to treatment from their regular VA providers as part of usual care. Pharmacotherapy is available at all sites in the form of nicotine replacement (patches, gum and lozenges) and bupropion.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="969"/>
            <count group_id="B2" value="969"/>
            <count group_id="B3" value="1938"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="662"/>
                    <measurement group_id="B2" value="646"/>
                    <measurement group_id="B3" value="1308"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="307"/>
                    <measurement group_id="B2" value="323"/>
                    <measurement group_id="B3" value="630"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="58.3" spread="11.6"/>
                    <measurement group_id="B2" value="58.9" spread="11.3"/>
                    <measurement group_id="B3" value="58.6" spread="11.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="128"/>
                    <measurement group_id="B2" value="125"/>
                    <measurement group_id="B3" value="253"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="841"/>
                    <measurement group_id="B2" value="844"/>
                    <measurement group_id="B3" value="1685"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="294"/>
                    <measurement group_id="B2" value="309"/>
                    <measurement group_id="B3" value="603"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="603"/>
                    <measurement group_id="B2" value="595"/>
                    <measurement group_id="B3" value="1198"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                    <measurement group_id="B2" value="35"/>
                    <measurement group_id="B3" value="79"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="969"/>
                    <measurement group_id="B2" value="969"/>
                    <measurement group_id="B3" value="1938"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Cotinine-Validated Abstinence From Smoking</title>
        <description>The primary outcome will be cotinine-validated abstinence from smoking at 12-month follow-up.</description>
        <time_frame>12 months</time_frame>
        <population>Cotinine samples were obtained by mail from 53/76 people reporting abstinence in the intervention arm and 44/58 people reporting abstinence in the control arm. Note that this reflects a &quot;complete case analysis&quot;, only including people for whom outcome data are available.</population>
        <group_list>
          <group group_id="O1">
            <title>Proactive Outreach</title>
            <description>Intervention arm participants received: (1) 12 sessions of proactive telephone cessation counseling, (2) coordination of cessation medications from a VA provider, (3) mailed stress reduction materials, (4) engagement of their regular mental health provider in the treatment process through CPRS progress notes, to which their provider will be added as signer.</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Control arm participants received a mailed list of local VA and non-VA smoking cessation services that they can access on their own. In addition, patients randomized to the control group received treatment or referrals to treatment from their regular VA providers as part of usual care. Pharmacotherapy is available at all sites in the form of nicotine replacement (patches, gum and lozenges) and bupropion.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Cotinine-Validated Abstinence From Smoking</title>
          <description>The primary outcome will be cotinine-validated abstinence from smoking at 12-month follow-up.</description>
          <population>Cotinine samples were obtained by mail from 53/76 people reporting abstinence in the intervention arm and 44/58 people reporting abstinence in the control arm. Note that this reflects a &quot;complete case analysis&quot;, only including people for whom outcome data are available.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="53"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36"/>
                    <measurement group_id="O2" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Self-Reporting 7-Day Abstinence From Cigarettes</title>
        <description>At 12 month follow-up, participants were asked if the had smoked any cigarettes in the last 7 days</description>
        <time_frame>12 months</time_frame>
        <population>We used a &quot;complete case&quot; analysis, excluding participants for whom information was not available at 12 month follow-up</population>
        <group_list>
          <group group_id="O1">
            <title>Proactive Outreach</title>
            <description>Intervention arm participants received: (1) 12 sessions of proactive telephone cessation counseling, (2) coordination of cessation medications from a VA provider, (3) mailed stress reduction materials, (4) engagement of their regular mental health provider in the treatment process through CPRS progress notes, to which their provider will be added as signer.</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Control arm participants received a mailed list of local VA and non-VA smoking cessation services that they can access on their own. In addition, patients randomized to the control group received treatment or referrals to treatment from their regular VA providers as part of usual care. Pharmacotherapy is available at all sites in the form of nicotine replacement (patches, gum and lozenges) and bupropion.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Self-Reporting 7-Day Abstinence From Cigarettes</title>
          <description>At 12 month follow-up, participants were asked if the had smoked any cigarettes in the last 7 days</description>
          <population>We used a &quot;complete case&quot; analysis, excluding participants for whom information was not available at 12 month follow-up</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="620"/>
                <count group_id="O2" value="701"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="119"/>
                    <measurement group_id="O2" value="96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Total adverse events were based on the results form 12 month follow-up</time_frame>
      <desc>Standard adverse even definitions were used</desc>
      <group_list>
        <group group_id="E1">
          <title>Intervention Arm</title>
          <description>Intervention arm participants received: (1) 12 sessions of proactive telephone cessation counseling, (2) coordination of cessation medications from a VA provider, (3) mailed stress reduction materials, (4) engagement of their regular mental health provider in the treatment process through CPRS progress notes, to which their provider will be added as signer.</description>
        </group>
        <group group_id="E2">
          <title>Control Arm</title>
          <description>Control arm participants received a mailed list of local VA and non-VA smoking cessation services that they can access on their own. In addition, patients randomized to the control group received treatment or referrals to treatment from their regular VA providers as part of usual care. Pharmacotherapy is available at all sites in the form of nicotine replacement (patches, gum and lozenges) and bupropion.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="969"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="969"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="39" subjects_at_risk="969"/>
                <counts group_id="E2" subjects_affected="28" subjects_at_risk="969"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Life-threating event</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="969"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="969"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Hospitalization</sub_title>
                <counts group_id="E1" subjects_affected="39" subjects_at_risk="969"/>
                <counts group_id="E2" subjects_affected="27" subjects_at_risk="969"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="969"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="969"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Scott Sherman</name_or_title>
      <organization>VA NY Harbor Healthcare System</organization>
      <phone>212-686-7500 ext 7386</phone>
      <email>scott.sherman@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

